Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

PhageLeads: Rapid Assessment of Phage Therapeutic Suitability Using an Ensemble Machine Learning Approach

Open access
Yukgehnaish, Kumarasan, Rajandas, Heera, Parimannan, Sivachandran, Manickam, Ravichandran, Marimuthu, Kasi, Petersen, Bent, Clokie, Martha R. J., Millard, Andrew, Sicheritz-Pontén, Thomas · 2022 · Viruses

Abstract

The characterization of therapeutic phage genomes plays a crucial role in the success rate of phage therapies. There are three checkpoints that need to be examined for the selection of phage candidates, namely, the presence of temperate markers, antimicrobial resistance (AMR) genes, and virulence genes. However, currently, no single-step tools are available for this purpose. Hence, we have developed a tool capable of checking all three conditions required for the selection of suitable therapeutic phage candidates. This tool consists of an ensemble of machine-learning-based predictors for determining the presence of temperate markers (integrase, Cro/CI repressor, immunity repressor, DNA partitioning protein A, and antirepressor) along with the integration of the ABRicate tool to determine the presence of antibiotic resistance genes and virulence genes. Using the biological features of the temperate markers, we were able to predict the presence of the temperate markers with high MCC scores (>0.70), corresponding to the lifestyle of the phages with an accuracy of 96.5%. Additionally, the screening of 183 lytic phage genomes revealed that six phages were found to contain AMR or virulence genes, showing that not all lytic phages are suitable to be used for therapy. The suite of predictors, PhageLeads, along with the integrated ABRicate tool, can be accessed online for in silico selection of suitable therapeutic phage candidates from single genome or metagenomic contigs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/v14020342

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 41

  1. Barr, 2019, Phage Therapy in the Postantibiotic Era, Clin. Microbiol. Rev., 32, e00066-18, 10.1128/CMR.00066-18 · DOI · Paper page
  2. Nuti, 2017, Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance, Curr. Med. Chem., 24, 4303, 10.2174/0929867324666170815102441 · doi:10.2174/0929867324666170815102441
  3. Ferry, 2020, Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients with Relapsing, S. Aureus Prosthetic Knee Infection, Front. Med., 7, 570572, 10.3389/fmed.2020.570572 · doi:10.3389/fmed.2020.570572
  4. Jault, 2019, Efficacy and Tolerability of a Cocktail of Bacteriophages to Treat Burn Wounds Infected by Pseudomonas Aeruginosa (PhagoBurn): A Randomised, Controlled, Double-Blind Phase 1/2 Trial, Lancet Infect. Dis., 19, 35, 10.1016/S1473-3099(18)30482-1 · DOI · Paper page
  5. Aslam, 2020, Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States, Open Forum Infect. Dis., 7, ofaa389, 10.1093/ofid/ofaa389 · DOI · Paper page
  6. Leitner, 2021, Intravesical Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial, Lancet Infect. Dis., 21, 427, 10.1016/S1473-3099(20)30330-3 · DOI · Paper page
  7. Onsea, J., Soentjens, P., Djebara, S., Merabishvili, M., Depypere, M., Spriet, I., De Munter, P., Debaveye, Y., Nijs, S., and Vanderschot, P. (2019). Bacteriophage Application for Difficult-to-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol. Viruses, 11. · DOI · Paper page
  8. Doub, J.B. (2020). Bacteriophage Therapy for Clinical Biofilm Infections: Parameters That Influence Treatment Protocols and Current Treatment Approaches. Antibiotics, 9. · DOI
  9. Philipson, C.W., Voegtly, L.J., Lueder, M.R., Long, K.A., Rice, G.K., Frey, K.G., Biswas, B., Cer, R.Z., Hamilton, T., and Bishop-Lilly, K.A. (2018). Characterizing Phage Genomes for Therapeutic Applications. Viruses, 10. · DOI · Paper page
  10. Wan, 2021, Phage-Based Target Discovery and Its Exploitation towards Novel Antibacterial Molecules, Curr. Opin. Biotechnol., 68, 1, 10.1016/j.copbio.2020.08.015 · DOI
  11. Toussaint, 2008, Reticulate Representation of Evolutionary and Functional Relationships between Phage Genomes, Mol. Biol. Evol., 25, 762, 10.1093/molbev/msn023 · DOI · Paper page
  12. Doub, 2021, Risk of Bacteriophage Therapeutics to Transfer Genetic Material and Contain Contaminants Beyond Endotoxins with Clinically Relevant Mitigation Strategies, Infect. Drug Resist., 14, 5629, 10.2147/IDR.S341265 · DOI
  13. Clokie, 2011, Phages in Nature, Bacteriophage, 1, 31, 10.4161/bact.1.1.14942 · DOI · Paper page
  14. Laanto, 2021, Black Box of Phage–Bacterium Interactions: Exploring Alternative Phage Infection Strategies, Open Biol., 11, 210188, 10.1098/rsob.210188 · DOI
  15. Colavecchio, 2017, Bacteriophages Contribute to the Spread of Antibiotic Resistance Genes among Foodborne Pathogens of the Enterobacteriaceae Family—A Review, Front. Microbiol., 8, 1108, 10.3389/fmicb.2017.01108 · DOI · Paper page
  16. Abedon, 2019, Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies, Microbiol. Mol. Biol. Rev., 83, e00012-19, 10.1128/MMBR.00012-19 · DOI · Paper page
  17. Moon, 2020, Freshwater Viral Metagenome Reveals Novel and Functional Phage-Borne Antibiotic Resistance Genes, Microbiome, 8, 75, 10.1186/s40168-020-00863-4 · DOI · Paper page
  18. Hassan, A.Y., Lin, J.T., Ricker, N., and Anany, H. (2021). The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?. Pharmaceuticals, 14. · DOI
  19. McNair, 2012, PHACTS, a Computational Approach to Classifying the Lifestyle of Phages, Bioinformatics, 28, 614, 10.1093/bioinformatics/bts014 · DOI · Paper page
  20. Hockenberry, 2021, BACPHLIP: Predicting Bacteriophage Lifestyle from Conserved Protein Domains, PeerJ, 9, e11396, 10.7717/peerj.11396 · DOI · Paper page
  21. Mistry, 2013, Challenges in Homology Search: HMMER3 and Convergent Evolution of Coiled-Coil Regions, Nucleic Acids Res., 41, e121, 10.1093/nar/gkt263 · DOI · Paper page
  22. Charoenkwan, P., Kanthawong, S., Schaduangrat, N., Yana, J., and Shoombuatong, W. (2020). PVPred-SCM: Improved Prediction and Analysis of Phage Virion Proteins Using a Scoring Card Method. Cells, 9. · DOI
  23. Cantu, V.A., Salamon, P., Seguritan, V., Redfield, J., Salamon, D., Edwards, R.A., and Segall, A.M. (2020). PhANNs, a Fast and Accurate Tool and Web Server to Classify Phage Structural Proteins. PLOS Comput. Biol., 16. · doi:10.1101/2020.04.03.023523
  24. Millard, 2021, Rapid Discovery of Novel Prophages Using Biological Feature Engineering and Machine Learning, NAR Genom. Bioinforma., 3, lqaa109, 10.1093/nargab/lqaa109 · DOI
  25. Hyman, P. (2019). Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth. Pharmaceuticals, 12. · DOI · Paper page
  26. Jia, 2017, CARD 2017: Expansion and Model-Centric Curation of the Comprehensive Antibiotic Resistance Database, Nucleic Acids Res., 45, D566, 10.1093/nar/gkw1004 · DOI · Paper page
  27. Kaminski, J., Gibson, M.K., Franzosa, E.A., Segata, N., Dantas, G., and Huttenhower, C. (2015). High-Specificity Targeted Functional Profiling in Microbial Communities with ShortBRED. PLOS Comput. Biol., 11. · DOI · Paper page
  28. Doster, 2020, MEGARes 2.0: A Database for Classification of Antimicrobial Drug, Biocide and Metal Resistance Determinants in Metagenomic Sequence Data, Nucleic Acids Res., 48, D561, 10.1093/nar/gkz1010 · DOI · Paper page
  29. (2021, November 17). National Database of Antibiotic Resistant Organisms (NDARO)—Pathogen Detection—NCBI, Available online: https://www.ncbi.nlm.nih.gov/pathogens/antimicrobial-resistance/.
  30. Chen, 2016, VFDB 2016: Hierarchical and Refined Dataset for Big Data Analysis--10 Years On, Nucleic Acids Res., 44, D694, 10.1093/nar/gkv1239 · DOI · Paper page
  31. Buchfink, 2021, Sensitive Protein Alignments at Tree-of-Life Scale Using DIAMOND, Nat. Methods, 18, 366, 10.1038/s41592-021-01101-x · DOI · Paper page
  32. Carattoli, 2014, In Silico Detection and Typing of Plasmids Using PlasmidFinder and Plasmid Multilocus Sequence Typing, Antimicrob. Agents Chemother., 58, 3895, 10.1128/AAC.02412-14 · DOI · Paper page
  33. Feldgarden, 2019, Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates, Antimicrob. Agents Chemother., 63, e00483-19, 10.1128/AAC.00483-19 · DOI · Paper page
  34. Ingle, 2016, In Silico Serotyping of E. Coli from Short Read Data Identifies Limited Novel O-Loci but Extensive Diversity of O:H Serotype Combinations within and between Pathogenic Lineages, Microb. Genom., 2, e000064
  35. Dion, 2020, Phage Diversity, Genomics and Phylogeny, Nat. Rev. Microbiol., 18, 125, 10.1038/s41579-019-0311-5 · DOI · Paper page
  36. Ofer, 2015, ProFET: Feature Engineering Captures High-Level Protein Functions, Bioinformatics, 31, 3429, 10.1093/bioinformatics/btv345 · DOI
  37. Cao, 2013, Propy: A Tool to Generate Various Modes of Chou’s PseAAC, Bioinformatics, 29, 960, 10.1093/bioinformatics/btt072 · DOI · Paper page
  38. Nanni, 2014, An Empirical Study of Different Approaches for Protein Classification, Sci. World J., 2014, e236717, 10.1155/2014/236717 · DOI
  39. van den Berg, B.A., Reinders, M.J., Roubos, J.A., and Ridder, D. (2014). de SPiCE: A Web-Based Tool for Sequence-Based Protein Classification and Exploration. BMC Bioinform., 15. · DOI
  40. Mavrich, 2017, Bacteriophage Evolution Differs by Host, Lifestyle and Genome, Nat. Microbiol., 2, 17112, 10.1038/nmicrobiol.2017.112 · DOI · Paper page
  41. Shitrit, 2021, Genetic Engineering of Marine Cyanophages Reveals Integration but Not Lysogeny in T7-like Cyanophages, ISME J., 16, 488, 10.1038/s41396-021-01085-8 · DOI

Cited by

See all 159

Metadata

Authors
Yukgehnaish, K., Rajandas, H., Parimannan, S., Manickam, R., Marimuthu, K., Petersen, B., Clokie, M. R. J., Millard, A., & Sicheritz-Pontén, T.
Venue
Viruses
Publisher
MDPI AG
Published
2022-02-08
Volume
14
Issue
2
Pages
342
ISSN
1999-4915 (ISSN-L)
OpenAlex
W4211094053
Cited by
159
References
10
FWCI
14.47
Type
journal article
Language
en
Open access
gold
Funders
Ministry of Higher Education of Malaysia ((JPT(BKPI)1000/016/018/25 (60)))

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PhageLeads: Rapid Assessment of Phage Therapeutic Suitability Using an Ensemble Machine Learning Approach. https://app.cochat.ai/papers/10.3390/v14020342
The paper
Yukgehnaish, K., Rajandas, H., Parimannan, S., Manickam, R., Marimuthu, K., Petersen, B., Clokie, M. R. J., Millard, A., & Sicheritz-Pontén, T. (2022). PhageLeads: Rapid Assessment of Phage Therapeutic Suitability Using an Ensemble Machine Learning Approach. Viruses. https://doi.org/10.3390/v14020342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.